Search

everythinglearnresearchcommunity

for

Search:↓

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Women with PCOS are more likely to develop kidney stones, especially those with certain PCOS types.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

The document concludes that managing hirsutism in PCOS involves long-term treatment guided by severity, using oral contraceptives and possibly antiandrogens, with attention to individual patient needs.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Checking the chin, thighs, upper lip, or lower abdomen is enough to predict hirsutism.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

The main causes of hirsutism in Jordanian women are PCOS and idiopathic hirsutism.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.